Zai Lab Ltd (NAS:ZLAB)
$ 20.16 0.15 (0.75%) Market Cap: 1.98 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.57 GF Score: 71/100

Zai Lab Ltd at Bank of America Merrill Lynch Health Care Conference Transcript

May 16, 2019 / 09:00PM GMT
Release Date Price: $27.05 (-4.79%)
Unidentified Analyst

My name is Ying Wong and I cover U.S. Biotech, large caps mostly for B of A. Very pleased to introduce our next presenting company, Zai Lab. And let me welcome Jonathan Wang, the Head of Development and SPV of Zai Lab. With that, let me turn over the podium for Jonathan. Welcome.

Jonathan J. Wang
Zai Lab Limited - Senior VP & Head of Business Development

Thank you very much, Ying, and thanks to Bank of America for this kind invitation to be here. So I'm very excited today to present our company, Zai Lab. I think, so first of all, we're a NASDAQ listed innovative biotech that is based in Shanghai, China, but we have offices around in U.S., as well as other parts of China. I think we're in a really once-in-a-lifetime opportunity in China in building a fully integrated company focusing on only innovative medicine. Our ultimate vision is to build a tech hitter or [true guide] of China, where for us, the core market is mainland in China, though we want to develop drugs with global standards and for global patients around the world. Specifically to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot